NVCRNovoCure Limited

$1B

FY 2022 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$538M+0.5% YoY

Gross Profit

$423M78.6% margin

Operating Income

-$90M-16.6% margin

Net Income

-$93M-17.2% margin

EPS (Diluted)

$-0.88

Cash Flow

Operating Cash Flow

$31M

Free Cash Flow

$9M

Stock-Based Comp.

$107M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$750M

Stockholders' Equity

$441M

Cash & Equivalents

$115M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$538M	$535M	+0.5%
Gross Profit	$423M	$420M	+0.7%
Operating Income	-$90M	-$44M	-101.9%
Net Income	-$93M	-$58M	-58.6%

NVCR FY 2022 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena